CNS Pharma (CNSP)
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States....
- Open
- 5.040
- High
- 5.500
- Low
- 4.900
- Prev. Close
- 5.130
- Volume
- 2.90K
- Turnover
- 15.21K
- Avg Price
- 5.241
- Bid/Ask Ratio
- 85.19%
- Amplitude
- 11.70%
- 52wk High
- 10.588
- Volume Ratio
- 0.21
- Turnover Ratio
- 0.20%
CNS Pharma Analyst Rating
View moreForecast & Rating
May 14, 2026Price forecast
$10.0081.82%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · Jul 2 at 06:58 AM
CNS Pharmaceuticals Announces Strategic Oncology-Neurology Realignment
- StockTitan · Jun 8 at 12:15 AM
CNS Pharmaceuticals CFO, Steve O'Loughlin, Highlights Company's Recent $22.5M Financing in Virtual Investor "What This Means" Segment | CNSP Stock News
- MorningStar · May 20 at 08:10 AM
CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress
- Earnings Watch · May 14 at 06:57 AM
CNS Pharma | 10-Q: FY2026 Q1 Revenue: USD 0
- benzinga_article · May 6 at 08:51 AM
What's Going On With CNS Pharmaceuticals Stock On Wednesday?
- benzinga_article · May 5 at 07:06 AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
